These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23728904)

  • 1. Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases.
    Wei Z; Zeng X; Xu J; Duan X; Yang J; Xie Y
    Head Neck; 2014 Jan; 36(1):71-6. PubMed ID: 23728904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of CYFRA 21-1 and CEA in patients with undifferentiated nasopharyngeal carcinoma before and after radiotherapy].
    Zhu WQ; Sun XD; Xie P; Kong L; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):367-70. PubMed ID: 21875467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
    Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
    Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pretreatment serum alkaline phosphatase in nasopharyngeal carcinoma.
    Xie Y; Wei ZB; Duan XW
    Asian Pac J Cancer Prev; 2014; 15(8):3547-53. PubMed ID: 24870755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
    Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
    Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects.
    Song XM; Wang ZJ; Cao WJ; Ji-Li ; Chen F; Wang SZ
    Int J Clin Oncol; 2016 Dec; 21(6):1038-1045. PubMed ID: 27405513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CYFRA 21-1, a new tumor marker, in nasopharyngeal carcinoma.
    Lin WY; Yen TC; Cheng KY; Wang SJ
    Neoplasma; 1998; 45(1):21-4. PubMed ID: 9604997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.
    Piao X; Kong TW; Chang SJ; Paek J; Chun M; Ryu HS
    Gynecol Oncol; 2015 Jul; 138(1):89-93. PubMed ID: 25913134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
    Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
    Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
    Du XJ; Chen L; Li WF; Tang LL; Mao YP; Guo R; Sun Y; Lin AH; Ma J
    Head Neck; 2017 Mar; 39(3):492-497. PubMed ID: 27997061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy.
    Sone K; Oguri T; Nakao M; Kagawa Y; Kurowaka R; Furuta H; Fukuda S; Uemura T; Takakuwa O; Kanemitsu Y; Ohkubo H; Takemura M; Maeno K; Ito Y; Sato H; Muramatsu H; Niimi A
    Anticancer Res; 2017 Feb; 37(2):935-939. PubMed ID: 28179355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma adrenomedullin levels and nasopharyngeal carcinoma prognosis.
    Zhang ZL; Huang SX; Lin S; Chai L
    Clin Chim Acta; 2015 Feb; 440():172-6. PubMed ID: 25433141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH
    Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):775-8. PubMed ID: 11510737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma.
    Zhu WQ; Yu JM; Sun XD; Xie P; Kong L
    Biomarkers; 2010 Nov; 15(7):602-7. PubMed ID: 20726807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
    Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
    Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
    Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
    Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia].
    Jmal A; Boussen H; Abdennebi M; Gara S; Harzallah L; Gritli S; Ladgham A; Guemira F; Ghanem A
    Bull Cancer; 2004 Apr; 91(4):369-72. PubMed ID: 15242321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.